Effect of Different Subcutaneous Injection Methods on Pain and Satisfaction

NCT ID: NCT06829407

Last Updated: 2025-02-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

112 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-20

Study Completion Date

2024-09-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study; In patients treated with subcutaneous heparin A randomized controlled trial was planned to determine the effect of the injection time and the device called "Palm Stimulator" to reduce the pain felt during injection.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain, Acute Injection Site

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

this study is an experimental, parallel-group (intervention-control), randomized controlled design
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

injection time

The application will be done by injecting for 30 seconds and then waiting for 10 seconds and ending the process.

Group Type EXPERIMENTAL

injection time

Intervention Type OTHER

give an injection

palm stimulator

By ensuring that the patient grasps the "palm stimulator" equipment in the palm during the injection and squeezes it in the palm throughout the injection. Tactile warning will be given. However, the injection process will last 10 seconds and the process will be terminated after waiting 10 seconds.

Group Type EXPERIMENTAL

palm stimulator

Intervention Type OTHER

give an injection

injection time and palm stimulator

Injection will be done for 30 seconds and then waited for 10 seconds and the process will be terminated, and the application will be done using equipment.

Group Type EXPERIMENTAL

injection time and palm stimulator

Intervention Type OTHER

give an injection

control group

The injection process will last 10 seconds and the process will be terminated after waiting 10 seconds.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

injection time

give an injection

Intervention Type OTHER

palm stimulator

give an injection

Intervention Type OTHER

injection time and palm stimulator

give an injection

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Above 18 years old
* The one who is literate,
* No physical, mental disabilities or communication difficulties,
* Low Molecular Weight Heparin in the treatment plan,
* No history of allergy,
* Agreeing to participate in the research,
* There is no scar tissue, incision or infection in the area to be injected,
* Patients who will receive a 1-day injection and whose pain score is between 1-10 according to VAS will be admitted.

Exclusion Criteria

* Who gave up participating in the research while continuing the research,
* Using subcutaneous insulin therapy,
* There is an amputation in the right/left arm area where the study will be performed,
* There is scar tissue, incision or signs of infection in the area to be injected,
* Patients who received injections for 1 day and whose pain score is 0 (zero) according to VAS will not be admitted.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Trakya University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ali Umit Yilmaz

Nurse

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Trakya Üniversitesi

Edirne, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TUTF-GOBAEK 202313|8

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.